BioElectronics Corporation Expands Panamanian Sales And Distribution

FREDERICK, Md., Sept. 17 /PRNewswire-FirstCall/ -- BioElectronics Corporation, , announced today that its Panama plastic surgery distribution agreement with VitalMedic, S.A. has been expanded to other medical specialties. The initial product shipments this summer have been enthusiastically received by plastic surgeons.

“During my recent visit to BioElectronics, I was excited to learn that ActiPatch has a much wider range of application than just plastic surgery. With this in mind, and based on the reception of ActiPatch by the plastic surgeons, we have initiated an expansion of our sales to most post-surgical care, orthopedics, sports medicine, foot care, and the retail target healthcare market,” said Gabriel Icaza, President of VitalMedic, S. A.

VitalMedic, S. A. is a medical distributor based in Panama which concentrates on innovative, reliable quality medical devices and represents Integra, Applied Medical, Mentor, Gore, etc. for critical medical specialties and hospital environments. For more information visit: http://www.vitalmedic.net/index.htm.

“With their understanding of the importance of innovative medical devices and their enthusiasm for ActiPatch, VitalMedic, S. A. will bring a vibrant approach to the introduction of the healing benefits that are derived from ActiPatch. This, in turn, brings a sense of excitement to BioElectronics,” said Andrew Whelan, President of BioElectronics.

BioElectronics Corporation is the maker of ActiPatch(TM). ActiPatch is a drug-free anti-inflammatory patch with an embedded battery operated microchip that delivers weeks of continuous pulsed therapy for a few cents per hour. The unique ActiPatch delivery system, using patented technology, provides a cost- effective, patient friendly method to reduce soft tissue pain and swelling.

For more information visit http://www.bioelectronicscorp.com.

Safe Harbor Statement:

This news release contains forward-looking statements related to future growth and earnings opportunities. Such statements are based upon certain assumptions and assessments made by management of both companies in light of current conditions, expected future developments and other factors it believes to be appropriate. Actual results may differ as a result of factors over which the companies have no control.

BioElectronics Corporation

CONTACT: Andrew J. Whelan, President, & CEO, BioElectronics Corporation,+1-301-874-4890, Fax: +1-301-874-6935, info@bioelectronicscorp.com

MORE ON THIS TOPIC